Emerging Infections : Microbial Threats to Health in the United States.
Oaks, Stanley C.
Emerging Infections : Microbial Threats to Health in the United States. - 1st ed. - 1 online resource (308 pages)
EMERGING INFECTIONS -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- RECOGNITION -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- Public Education and Behavioral Change -- 1 Background -- PLAGUE -- INFLUENZA -- OPTIMISM AND INDIFFERENCE -- Sanitation and Hygiene -- Quarantine -- Smallpox -- Poliomyelitis -- TROUBLE AHEAD -- Lyme Disease -- Peptic Ulcer -- Malaria -- Dengue -- Tuberculosis -- NEXT STEPS -- 2 Factors in Emergence -- THE CONCEPT OF EMERGENCE -- HUMAN DEMOGRAPHICS AND BEHAVIOR -- Population Growth, Density, and Distribution -- DENGUE -- Immunosuppression -- Sexual Activity and Substance Abuse -- TECHNOLOGY AND INDUSTRY -- Modern Medicine -- HEALTH CARE DELIVERY -- PREVENTION OF NOSOCOMIAL INFECTIONS -- Food Processing and Handling -- AGRICULTURAL CONDITIONS AND PRACTICES -- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES -- DEMOGRAPHICS -- CONSUMER ATTITUDES AND BEHAVIOR -- COMMERCE -- DIET AND FOOD PREPARATION -- Trichinosis -- Anisakiasis -- Water Treatment -- ECONOMIC DEVELOPMENT AND LAND USE -- Dam Building and Rift Valley Fever -- Reforestation and Lyme Disease -- Global Warming -- INTERNATIONAL TRAVEL AND COMMERCE -- Travel -- MALARIA -- Commerce -- HANTAAN AND RELATED HANTAVIRUSES -- THE FILOVIRUSES -- MICROBIAL ADAPTATION AND CHANGE -- Natural Variation/Mutation -- RNA VIRUSES -- Influenza A Virus -- Human Immunodeficiency Virus -- DNA VIRUSES -- Hepatitis B Virus -- BACTERIA -- Brazilian Purpuric Fever -- Selective Pressure and the Development of Resistance -- RESISTANCE TO ANTIBIOTICS -- Pneumococci -- Staphylococci and Enterococci -- Pseudomonas aeruginosa -- Mycobacterium tuberculosis -- RESISTANCE TO ANTIVIRALS -- Acyclovir and Herpes Simplex Virus. Zidovudine and Human Immunodeficiency Virus-1 -- RESISTANCE TO ANTIMALARIALS -- VECTOR RESISTANCE TO PESTICIDES -- New Understandings: Microbes as Cofactors in Chronic Disease -- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II -- ATHEROSCLEROSIS -- HUMAN PAPILLOMAVIRUS -- BREAKDOWN OF PUBLIC HEALTH MEASURES -- Inadequate Sanitation: Cholera -- Complacency -- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES -- War -- 3 Addressing the Threats -- RECOGNITION -- Surveillance in Action: The World Health Organization's Smallpox Eradication Program -- LESSONS FROM THE SMALLPOX EXPERIENCE -- Current U.S.-Supported Surveillance Efforts -- DOMESTIC EFFORTS -- Notifiable Diseases Surveillance -- Nosocomial Infections Surveillance -- Outbreak Surveillance -- Influenza Surveillance -- Access to Surveillance Information -- INTERNATIONAL EFFORTS -- Past Successes -- Loss of Capacity -- Current Efforts -- Multilateral International Surveillance Efforts -- WORLD HEALTH ORGANIZATION -- PAN AMERICAN HEALTH ORGANIZATION -- The Concept of Global Surveillance -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- THE ROCKEFELLER FOUNDATION -- NATIONAL INSTITUTES OF HEALTH -- CENTERS FOR DISEASE CONTROL -- DEPARTMENT OF DEFENSE -- OTHER PROGRAMS -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- VECTOR-CONTROL RESOURCES -- PESTICIDES FOR VECTOR CONTROL -- Public Education and Behavioral Change -- References -- Appendixes -- A Task Forces -- TASK FORCE 1 -- Bacteria, Rickettsiae, and Chlamydiae -- TASK FORCE 2 -- Viruses -- TASK FORCE 3 -- Protozoans, Helminths, and Fungi -- TASK FORCE 4 -- Policy Options -- TASK FORCE 5 -- Recommendations -- B Catalog of Emerging Infectious Disease Agents -- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE -- Aeromonas -- Borrelia burgdorferi -- Campylobacter jejuni. Chlamydia pneumoniae (TWAR Strain) -- Chlamydia trachomatis -- Clostridium difficile -- Ehrlichia chaffeensis -- Escherichia coli O157:H7 -- Haemophilus influenzae biogroup aegyptius -- Helicobacter pylori -- Legionella pneumophila -- Listeria monocytogenes -- Mycobacterium tuberculosis -- Staphylococcus aureus (and Toxic Shock Syndrome) -- Streptococcus pyogenes (Group A) -- Vibrio cholerae -- Vibrio vulnificus -- EMERGENT VIRUSES -- Bovine Spongiform Encephalopathy Agent -- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis) -- Chikungunya Virus -- Crimean-Congo Hemorrhagic Fever Virus -- Dengue Virus -- Filoviruses (Marburg, Ebola) -- Hantaviruses (Hantaan, Puumala, and Seoul) -- Hepatitis B Virus -- Hepatitis C Virus -- Hepatitis E Agent -- Human Herpesvirus-6 -- Human Immunodeficiency Virus (HIV), Types 1 and 2 -- Human Papillomavirus (HPV) -- Human Parvovirus B19 -- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2 -- Influenza A Virus -- Japanese Encephalitis Virus -- Lassa Virus -- Measles Virus -- Norwalk and Norwalk-like Agents -- Rabies Virus -- Rift Valley Fever Virus -- Ross River Virus -- Rotavirus -- Venezuelan Equine Encephalitis (VEE) Virus -- Yellow Fever Virus -- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI -- Anisakis -- Babesia -- Candida -- Crytococcus -- Cryptosporidium -- Giardia lamblia -- Microsporidia -- Plasmodium -- Pneumocystis carinii -- Strongyloides stercoralis -- Toxoplasma gondii -- C Global Resources for Infectious Disease Surveillance -- U.S. and U.S. Affiliated -- U.S. Department of Defense -- Public Health Service -- International -- World Health Organization, Geneva, Switzerland -- Pasteur Institutes -- D Committee and Staff Biographies -- COMMITTEE -- STAFF -- Glossary -- Acronyms and Abbreviations -- Index.
9780309584630
Emerging infectious diseases-United States.
Electronic books.
RA643.5 .E43 1992
614.4/273
Emerging Infections : Microbial Threats to Health in the United States. - 1st ed. - 1 online resource (308 pages)
EMERGING INFECTIONS -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- RECOGNITION -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- Public Education and Behavioral Change -- 1 Background -- PLAGUE -- INFLUENZA -- OPTIMISM AND INDIFFERENCE -- Sanitation and Hygiene -- Quarantine -- Smallpox -- Poliomyelitis -- TROUBLE AHEAD -- Lyme Disease -- Peptic Ulcer -- Malaria -- Dengue -- Tuberculosis -- NEXT STEPS -- 2 Factors in Emergence -- THE CONCEPT OF EMERGENCE -- HUMAN DEMOGRAPHICS AND BEHAVIOR -- Population Growth, Density, and Distribution -- DENGUE -- Immunosuppression -- Sexual Activity and Substance Abuse -- TECHNOLOGY AND INDUSTRY -- Modern Medicine -- HEALTH CARE DELIVERY -- PREVENTION OF NOSOCOMIAL INFECTIONS -- Food Processing and Handling -- AGRICULTURAL CONDITIONS AND PRACTICES -- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES -- DEMOGRAPHICS -- CONSUMER ATTITUDES AND BEHAVIOR -- COMMERCE -- DIET AND FOOD PREPARATION -- Trichinosis -- Anisakiasis -- Water Treatment -- ECONOMIC DEVELOPMENT AND LAND USE -- Dam Building and Rift Valley Fever -- Reforestation and Lyme Disease -- Global Warming -- INTERNATIONAL TRAVEL AND COMMERCE -- Travel -- MALARIA -- Commerce -- HANTAAN AND RELATED HANTAVIRUSES -- THE FILOVIRUSES -- MICROBIAL ADAPTATION AND CHANGE -- Natural Variation/Mutation -- RNA VIRUSES -- Influenza A Virus -- Human Immunodeficiency Virus -- DNA VIRUSES -- Hepatitis B Virus -- BACTERIA -- Brazilian Purpuric Fever -- Selective Pressure and the Development of Resistance -- RESISTANCE TO ANTIBIOTICS -- Pneumococci -- Staphylococci and Enterococci -- Pseudomonas aeruginosa -- Mycobacterium tuberculosis -- RESISTANCE TO ANTIVIRALS -- Acyclovir and Herpes Simplex Virus. Zidovudine and Human Immunodeficiency Virus-1 -- RESISTANCE TO ANTIMALARIALS -- VECTOR RESISTANCE TO PESTICIDES -- New Understandings: Microbes as Cofactors in Chronic Disease -- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II -- ATHEROSCLEROSIS -- HUMAN PAPILLOMAVIRUS -- BREAKDOWN OF PUBLIC HEALTH MEASURES -- Inadequate Sanitation: Cholera -- Complacency -- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES -- War -- 3 Addressing the Threats -- RECOGNITION -- Surveillance in Action: The World Health Organization's Smallpox Eradication Program -- LESSONS FROM THE SMALLPOX EXPERIENCE -- Current U.S.-Supported Surveillance Efforts -- DOMESTIC EFFORTS -- Notifiable Diseases Surveillance -- Nosocomial Infections Surveillance -- Outbreak Surveillance -- Influenza Surveillance -- Access to Surveillance Information -- INTERNATIONAL EFFORTS -- Past Successes -- Loss of Capacity -- Current Efforts -- Multilateral International Surveillance Efforts -- WORLD HEALTH ORGANIZATION -- PAN AMERICAN HEALTH ORGANIZATION -- The Concept of Global Surveillance -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- THE ROCKEFELLER FOUNDATION -- NATIONAL INSTITUTES OF HEALTH -- CENTERS FOR DISEASE CONTROL -- DEPARTMENT OF DEFENSE -- OTHER PROGRAMS -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- VECTOR-CONTROL RESOURCES -- PESTICIDES FOR VECTOR CONTROL -- Public Education and Behavioral Change -- References -- Appendixes -- A Task Forces -- TASK FORCE 1 -- Bacteria, Rickettsiae, and Chlamydiae -- TASK FORCE 2 -- Viruses -- TASK FORCE 3 -- Protozoans, Helminths, and Fungi -- TASK FORCE 4 -- Policy Options -- TASK FORCE 5 -- Recommendations -- B Catalog of Emerging Infectious Disease Agents -- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE -- Aeromonas -- Borrelia burgdorferi -- Campylobacter jejuni. Chlamydia pneumoniae (TWAR Strain) -- Chlamydia trachomatis -- Clostridium difficile -- Ehrlichia chaffeensis -- Escherichia coli O157:H7 -- Haemophilus influenzae biogroup aegyptius -- Helicobacter pylori -- Legionella pneumophila -- Listeria monocytogenes -- Mycobacterium tuberculosis -- Staphylococcus aureus (and Toxic Shock Syndrome) -- Streptococcus pyogenes (Group A) -- Vibrio cholerae -- Vibrio vulnificus -- EMERGENT VIRUSES -- Bovine Spongiform Encephalopathy Agent -- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis) -- Chikungunya Virus -- Crimean-Congo Hemorrhagic Fever Virus -- Dengue Virus -- Filoviruses (Marburg, Ebola) -- Hantaviruses (Hantaan, Puumala, and Seoul) -- Hepatitis B Virus -- Hepatitis C Virus -- Hepatitis E Agent -- Human Herpesvirus-6 -- Human Immunodeficiency Virus (HIV), Types 1 and 2 -- Human Papillomavirus (HPV) -- Human Parvovirus B19 -- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2 -- Influenza A Virus -- Japanese Encephalitis Virus -- Lassa Virus -- Measles Virus -- Norwalk and Norwalk-like Agents -- Rabies Virus -- Rift Valley Fever Virus -- Ross River Virus -- Rotavirus -- Venezuelan Equine Encephalitis (VEE) Virus -- Yellow Fever Virus -- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI -- Anisakis -- Babesia -- Candida -- Crytococcus -- Cryptosporidium -- Giardia lamblia -- Microsporidia -- Plasmodium -- Pneumocystis carinii -- Strongyloides stercoralis -- Toxoplasma gondii -- C Global Resources for Infectious Disease Surveillance -- U.S. and U.S. Affiliated -- U.S. Department of Defense -- Public Health Service -- International -- World Health Organization, Geneva, Switzerland -- Pasteur Institutes -- D Committee and Staff Biographies -- COMMITTEE -- STAFF -- Glossary -- Acronyms and Abbreviations -- Index.
9780309584630
Emerging infectious diseases-United States.
Electronic books.
RA643.5 .E43 1992
614.4/273